Colinz Laboratories Limited (COLINZ.BO)
INR 70.32
(3.44%)
INR 70.32
(3.44%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 9.74 Million | 4.02 Million | 4.67 Million | 21.58 Million | 5.8 Million | 1.16 Million |
| Net Income | 4.86 Million | 5.99 Million | 4.8 Million | 2.45 Million | 1.76 Million | 1.55 Million |
| Depreciation & Amortization | 1.3 Million | 1.28 Million | 2.01 Million | 1.91 Million | 1.94 Million | 2.15 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 3.7 Million | -717 Thousand | 316 Thousand | 18.8 Million | 3.44 Million | -2.05 Million |
| Other non-cash items | -618 Thousand | -2.54 Million | -2.46 Million | -1.59 Million | -1.34 Million | -502.85 Thousand |
| Investing Cash Flow | 69 Thousand | 87 Thousand | -325 Thousand | -1.54 Million | -375.14 Thousand | -106.66 Thousand |
| Investments in PPE | -9.74 Million | - | -375 Thousand | -1.57 Million | -437.55 Thousand | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | -140.15 Thousand |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 69 Thousand | 87 Thousand | 50 Thousand | 31 Thousand | 62.4 Thousand | 33.48 Thousand |
| Financing Cash Flow | 2.96 Million | 1.11 Million | 903 Thousand | 801 Thousand | 618.87 Thousand | 176.15 Thousand |
| Debt repayment | -2.96 Million | -2.11 Million | -5.08 Million | -6.11 Million | -2.94 Million | -2.54 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 2.66 Million | 3.22 Million | 5.98 Million | 6.92 Million | 3.56 Million | 2.72 Million |
| Accounts receivables | 2.74 Million | 719 Thousand | 918 Thousand | 1.93 Million | 1.86 Million | 52.18 Thousand |
| Accounts payables | -568 Thousand | 1.79 Million | -690 Thousand | 1.74 Million | 265.73 Thousand | -3.32 Million |
| Inventory | 919 Thousand | -135 Thousand | 3.21 Million | 4.44 Million | 2.07 Million | 696.07 Thousand |
| Other working capital | 604 Thousand | -3.09 Million | -3.12 Million | 10.67 Million | -757.24 Thousand | 524.19 Thousand |
| Cash at beginning of period | 19.65 Million | 52.06 Million | 46.81 Million | 26.08 Million | 19.92 Million | 18.69 Million |
| Cash at end of period | 70 Million | 57.28 Million | 52.06 Million | 46.81 Million | 25.97 Million | 19.92 Million |
| Capital Expenditure | -9.74 Million | - | -375 Thousand | -1.57 Million | -437.55 Thousand | - |
| Effect of forex changes on cash | - | - | - | -100 Thousand | -1.00 | -1.00 |
| Net cash flow / Change in cash | 50.34 Million | 5.22 Million | 5.24 Million | 20.73 Million | 6.04 Million | 1.22 Million |
| Free Cash Flow | - | 4.02 Million | 4.29 Million | 20 Million | 5.36 Million | 1.16 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.37 Million | 1.36 Million | 4.86 Million | 1.06 Million | 1.23 Million | 1.21 Million |
| Depreciation & Amortization | - | - | 1.3 Million | 326 Thousand | 326 Thousand | 326 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | 3.7 Million | - | 1.81 Million | 1.81 Million |
| Other non-cash items | -1.37 Million | -1.36 Million | -618 Thousand | -1.06 Million | -1.23 Million | -1.21 Million |
| Investing Cash Flow | - | - | 69 Thousand | - | 30 Thousand | 30 Thousand |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 69 Thousand | - | 30 Thousand | 30 Thousand |
| Financing Cash Flow | - | - | 2.96 Million | - | 484.5 Thousand | 484.5 Thousand |
| Debt repayment | - | - | -2.96 Million | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | 2.66 Million | - | 484.5 Thousand | 484.5 Thousand |
| Accounts receivables | - | - | 2.74 Million | - | -342.5 Thousand | -342.5 Thousand |
| Accounts payables | - | - | -568 Thousand | - | - | - |
| Inventory | - | - | 919 Thousand | - | 120 Thousand | 120 Thousand |
| Other working capital | - | - | 604 Thousand | - | 2.04 Million | 2.04 Million |
| Cash at beginning of period | - | - | 19.65 Million | 24.81 Million | 23.57 Million | 19.65 Million |
| Cash at end of period | - | - | 70 Million | 1.06 Million | 24.81 Million | 1.21 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | -1.86 Million | -1.88 Million |
| Net cash flow / Change in cash | - | - | 50.34 Million | -23.74 Million | 1.23 Million | -18.44 Million |
| Free Cash Flow | - | - | 9.74 Million | 1.06 Million | 2.57 Million | 2.57 Million |
OMHI
7952
GFIOF
002406
NYMX
BAGFF